Online citations, reference lists, and bibliographies.

P16 Positive Oropharyngeal Squamous Cell Carcinoma:An Entity With A Favorable Prognosis Regardless Of Tumor HPV Status

James S. Lewis, W. L. Thorstad, Rebecca D. Chernock, Bruce H. Haughey, James Tin Hang Yip, Qin Rui Zhang, Samir K El-Mofty
Published 2010 · Medicine
Cite This
Download PDF
Analyze on Scholarcy
Share
BackgroundIn the human papillomavirus (HPV) era, the best way to assess oropharyngeal squamous carcinomas (SCC) for risk stratification is not clear. Many recommend use of both p16 immunohistochemistry and HPV in situ hybridization (ISH). A significant minority of tumors are p16 positive and HPV ISH negative, the significance of which is unclear. MethodsTwo hundred thirty-nine oropharyngeal SCC were tested by immunohistochemistry for p16 and by ISH for high-risk HPV. For p16 positive, HPV ISH negative cases, PCR was conducted for HPV. The findings were correlated with pathologic and clinical findings. ResultsOf the 239 cases, 187 (78%) were positive for p16. Of these, 139 (74%) were positive for HPV by ISH. Of the remaining 48 cases, 45 had material for PCR. Nineteen were positive for HPV, leaving a group of 26 p16 positive and HPV undetectable SCCs. In the p16 positive cohort, there was no difference in survival between HPV ISH positive and negative cases. Comparing the HPV ISH positive and HPV ISH and PCR negative SCC, there was again no difference in survival. p16 positive, HPV negative SCC still had significantly better survival than p16 negative SCC in univariate and multivariate analysis. ConclusionsOutcomes for p16 positive, HPV negative oropharyngeal SCC are not significantly different from p16 positive, HPV positive tumors and are significantly better than for p16 negative tumors. These results suggest that p16 immunohistochemistry alone is the best test to use for risk stratification in oropharyngeal SCC.
This paper references
10.1002/hed.21269
Head and neck squamous cell cancer and the human papillomavirus: summary of a National Cancer Institute State of the Science Meeting, November 9-10, 2008, Washington, D.C.
David Adelstein (2009)
10.1093/jnci/90.21.1626
Oral cancer risk in relation to sexual history and evidence of human papillomavirus infection.
Stephen M Schwartz (1998)
10.1016/S1470-2045(09)70311-0
Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival.
James A. Bonner (2010)
10.1111/j.1365-2559.2004.01881.x
Adenosquamous carcinoma of the head and neck: criteria for diagnosis in a study of 12 cases.
Llúcia Alos (2004)
10.1007/s12105-009-0100-y
The Changing Face of Head and Neck Cancer in the 21st Century: The Impact of HPV on the Epidemiology and Pathology of Oral Cancer
William H Westra (2009)
10.1002/ijc.23458
Marked differences in survival rate between smokers and nonsmokers with HPV 16-associated tonsillar carcinomas.
Harriët C. Hafkamp (2008)
10.1002/ijc.24842
Is the improved prognosis of p16 positive oropharyngeal squamous cell carcinoma dependent of the treatment modality?
Claude A. Fischer (2009)
10.1056/NEJMoa065497
Case-control study of human papillomavirus and oropharyngeal cancer.
Gypsyamber D’souza (2007)
10.1016/j.otohns.2008.11.025
HPV-16 infection predicts treatment outcome in oropharyngeal squamous cell carcinoma
Anthony C Nichols (2009)
10.1001/archotol.1989.01860300085023
Undifferentiated carcinoma of nasopharyngeal type of tonsil.
Jerzy Klijanienko (1989)
10.1002/ijc.22980
A novel algorithm for reliable detection of human papillomavirus in paraffin embedded head and neck cancer specimen.
Serge J. Smeets (2007)
10.1086/597755
Oral sexual behaviors associated with prevalent oral human papillomavirus infection.
Gypsyamber D’souza (2009)
10.1158/1078-0432.CCR-05-0587
Tissue Distribution of Human Papillomavirus 16 DNA Integration in Patients with Tonsillar Carcinoma
Shahnaz Begum (2005)
10.1016/S1041-892X(10)79613-X
Transoral Laser Microsurgery (TLM)±Adjuvant Therapy for Advanced Stage Oropharyngeal Cancer: Outcomes and Prognostic Factors
Markus Gapany (2010)
10.1097/PAS.0b013e31816380ec
Basaloid Squamous Cell Carcinoma of the Head and Neck is a Mixed Variant That Can be Further Resolved by HPV Status
Shanaz Begum (2008)
Prevalence of human papillomavirus type 16 DNA in squamous cell carcinoma of the palatine tonsil, and not the oral cavity, in young patients: a distinct clinicopathologic and molecular disease
SK El-Mofty (2003)
10.1016/S0304-3835(00)00699-6
High frequency of homozygous deletion and methylation of p16(INK4A) gene in oral squamous cell carcinomas.
Yuuji Nakahara (2001)
10.1002/cncr.24752
Survey on human papillomavirus/p16 screening use in oropharyngeal carcinoma patients in the United States.
Asal N. Shoushtari (2010)
10.1200/JCO.2009.23.1670
Comparative prognostic value of HPV16 E6 mRNA compared with in situ hybridization for human oropharyngeal squamous carcinoma.
Wei Shi (2009)
10.1002/cncr.20998
Tongue and tonsil carcinoma: increasing trends in the U.S. population ages 20-44 years.
Caroline H. Shiboski (2005)
10.1016/j.tripleo.2008.08.027
Alterations of p16 and p14ARF genes and their 9p21 locus in oral squamous cell carcinoma.
Shinsuke Ohta (2009)
10.1016/j.jcv.2004.11.017
Human papillomavirus (HPV) in head and neck cancer.
Stina M Syrjänen (2005)
10.1002/ijc.24339
Incidence of human papillomavirus (HPV) positive tonsillar carcinoma in Stockholm, Sweden: an epidemic of viral-induced carcinoma?
Anders Näsman (2009)
10.1016/S0046-8177(86)80422-1
Basaloid-squamous carcinoma of the tongue, hypopharynx, and larynx: report of 10 cases.
Stephanie L. Wain (1986)
Prognostic significance of HPV and p16 status in patients with oropharyngeal cancer treated on a large international phase III trial.
Danny Rischin (2009)
HEAD AND NECK SQUAMOUS CELL CANCER AND THE HUMAN PAPILLOMAVIRUS : SUMMARY OF A NATIONAL CANCER INSTITUTE STATE OF THE SCIENCE MEETING , NOVEMBER
David Adelstein (2009)
10.1200/JCO.2007.12.7662
EGFR, p16, HPV Titer, Bcl-xL and p53, sex, and smoking as indicators of response to therapy and survival in oropharyngeal cancer.
Bhavna Kumar (2008)
10.1016/j.molonc.2007.08.005
Human papillomavirus is a favourable prognostic factor in tonsillar cancer and its oncogenic role is supported by the expression of E6 and E7.
David H. Lindquist (2007)
10.1002/IJC.22851
Survival of squamous cell carcinoma of the head and neck in relation to human papillomavirus infection: review and meta-analysis.
Camille C R Ragin (2007)
10.1158/1078-0432.CCR-04-0448
Prognostic Significance of p16 Protein Levels in Oropharyngeal Squamous Cell Cancer
Paul Maurice Weinberger (2004)
10.1128/JCM.00286-09
Validation of the SPF10 LiPA Human Papillomavirus Typing Assay Using Formalin-Fixed Paraffin-Embedded Cervical Biopsy Samples
Barbara Dal Bello (2009)
10.1093/jnci/djn011
Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial.
Carole Fakhry (2008)
Survey on human papillomavirus/p16 screening use in orophary carcinoma patients
AN Shoushtari (2009)
10.1016/S0046-8177(99)90217-4
Expression of p16, Rb, and cyclin D1 gene products in oral and laryngeal squamous carcinoma: biological and clinical implications.
Adel K. El-Naggar (1999)
10.1002/lary.20552
Transoral laser microsurgery (TLM) +/- adjuvant therapy for advanced stage oropharyngeal cancer: outcomes and prognostic factors.
Jason T. Rich (2009)
10.1097/00000478-200311000-00010
Prevalence of Human Papillomavirus Type 16 DNA in Squamous Cell Carcinoma of the Palatine Tonsil, and Not the Oral Cavity, in Young Patients: A Distinct Clinicopathologic and Molecular Disease Entity
Samir K El-Mofty (2003)
10.1128/JCM.01299-07
Evaluation of a Commercialized In Situ Hybridization Assay for Detecting Human Papillomavirus DNA in Tissue Specimens from Patients with Cervical Intraepithelial Neoplasia and Cervical Carcinoma
Ming Guo (2007)
HEAD AND NECK SQUAMOUS CELL CANCER AND THE HUMAN PAPILLOMAVIRUS: SUMMARY OF A NATIONAL CANCER INSTITUTE STATE OF THE SCIENCE MEETING,
David J. Adelstein (2009)
10.1016/j.ijrobp.2007.04.086
Concurrent chemoradiotherapy in the management of squamous cell cancer of the oropharynx: current standards and future directions.
David Adelstein (2007)
Head and neck squamous cell cancer and the human papillomavirus : summary of a National Cancer Institute State of the Science Meeting , November 9 - 10 , 2008 , Washington , D . C . Head Neck
DJ Adelstein (2009)
10.1007/s12105-009-0126-1
HPV-Related Nonkeratinizing Squamous Cell Carcinoma of the Oropharynx: Utility of Microscopic Features in Predicting Patient Outcome
Rebecca D. Chernock (2009)



This paper is referenced by
10.3389/fonc.2018.00273
Patient Selection in Human Papillomavirus Related Oropharyngeal Cancer: The Added Value of Prognostic Models in the New TNM 8th Edition Era
Sarah Deschuymer (2018)
10.1200/JGO.18.00219
Temporal Changes in Head and Neck Cancer Incidence in Thailand Suggest Changing Oropharyngeal Epidemiology in the Region
Ilona Argirion (2019)
Pre-therapeutic histological and cytological assessment in head and neck squamous cell carcinomas. French Society of Otorhinolaryngology Guidelines – 2012
Cécile Badouala (2012)
10.1097/PAS.0000000000000666
Assessing p16 Status of Oropharyngeal Squamous Cell Carcinoma by Combined Assessment of the Number of Cells Stained and the Confluence of p16 Staining: A Validation by Clinical Outcomes
Samuel P. Barasch (2016)
10.5981/JJHNC.39.334
Combined analysis of HPV status and p16 expression in patients with oropharyngeal squamous cell carcinoma
Takatsugu Mizumachi (2013)
10.1097/PAS.0b013e31823f2f17
HPV-associated Neuroendocrine Carcinoma of the Oropharynx: A Rare New Entity With Potentially Aggressive Clinical Behavior
Stefan Erich Julius Kraft (2012)
10.1177/0300985812452582
The Presence of p16CDKN2A Protein Immunostaining Within Feline Nasal Planum Squamous Cell Carcinomas Is Associated With an Increased Survival Time and the Presence of Papillomaviral DNA
John S Munday (2013)
10.1007/s00428-015-1725-8
p16INK4a overexpression is associated with CDKN2A mutation and worse prognosis in HPV-negative laryngeal squamous cell carcinomas
Ana B. Larque (2015)
Inverted papilloma and sinonasal malignancies in Sweden
Alexandra Elliot (2018)
10.12998/wjcc.v2.i6.172
Role of human papillomavirus in oropharyngeal squamous cell carcinoma: A review.
Robbie S R Woods (2014)
10.5858/arpa.2014-0167-RA
Review and updates of immunohistochemistry in selected salivary gland and head and neck tumors.
Shaobo Zhu (2015)
10.1007/s00405-019-05338-3
Roles of Ki-67 and p16 as biomarkers for unknown primary head and neck squamous cell carcinoma
Toshiya Maebayashi (2019)
10.3233/CBM-182106
The association of Bcl-xL and p53 expression with survival outcomes in oropharyngeal cancer.
Hedyeh Ziai (2019)
10.1158/0008-5472.CAN-13-2479
p16INK4a impairs homologous recombination-mediated DNA repair in human papillomavirus-positive head and neck tumors.
Rüveyda Dok (2014)
Transforming growth factor beta1 genotype, p16 expression, and treatment outcome in head and neck squamous cell carcinoma
Marie Lundberg (2013)
Oral cavity cancer: diagnosis, treatment and follow-up
Vincent Grégroire (2014)
10.1002/ijc.28112
Head and neck cancer: from anatomy to biology.
Pinaki Bose (2013)
Prognostic Markers in Head and Neck Cancer
Catriona M. Douglas (2011)
Okužba s človeškimi papilomavirusi pri bolnikih z invertiranimi papilomi nosu in obnosnih votlin ter s pridruženim ploščatoceličnim karcinomom
Klemen Jenko (2018)
10.1097/PGP.0000000000000568
Prognostic Significance of P16 Expression and P53 Expression in Primary Vaginal Cancer
Chika R Nwachukwu (2018)
10.1053/j.semdp.2015.02.022
Human papillomavirus-related head and neck squamous cell carcinoma variants.
Samir K El-Mofty (2015)
10.18632/oncotarget.15582
DEK associates with tumor stage and outcome in HPV16 positive oropharyngeal squamous cell carcinoma
Eric A. Smith (2017)
10.1159/000496158
Current Status of p16 Immunohistochemistry and HPV Testing in Fine Needle Aspiration Specimens of the Head and Neck
Jalal B Jalaly (2019)
10.1002/cncr.27696
A microRNA expression signature for the prognosis of oropharyngeal squamous cell carcinoma.
Ge Gao (2013)
10.1053/j.semdp.2014.12.006
The role of cytology in the era of HPV-related head and neck carcinoma.
Sinchita Roy-Chowdhuri (2015)
10.1038/ctg.2016.8
Anal Neoplasia in Inflammatory Bowel Disease Is Associated With HPV and Perianal Disease
Joannie Ruel (2016)
10.1007/s00405-015-3771-x
Management of locally advanced HPV-related oropharyngeal squamous cell carcinoma: where are we?
Stuart E. Samuels (2015)
10.1016/j.humpath.2017.02.021
RNA chromogenic in situ hybridization assay with clinical automated platform is a sensitive method in detecting high-risk human papillomavirus in squamous cell carcinoma.
Javier E Mendez-Pena (2017)
10.1007/s12253-014-9773-y
The Role of Protein p16INK4a in Glottic Laryngeal Squamous Cell Carcinoma
David Kalfert (2014)
10.1016/j.humpath.2013.09.006
African Americans with oropharyngeal carcinoma have significantly poorer outcomes despite similar rates of human papillomavirus-mediated carcinogenesis.
Tatyana Isayeva (2014)
10.1111/cas.12287
P16INK4A as a surrogate biomarker for human papillomavirus-associated oropharyngeal carcinoma: consideration of some aspects.
Hong-zhi Wang (2013)
10.1684/bdc.2014.1966
[Quality control in pathology and theranostics in head and neck cancers].
Claire Faure (2014)
See more
Semantic Scholar Logo Some data provided by SemanticScholar